ERANN BULMAN: Open Payments
NPI 1841980869 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,269 in 180 payments from 43 companies in 2025. Trend: 2023 $3,101 · 2024 $5,373 · 2025 $4,269
Food & beverage: $4,170Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $370 |
| Novartis Pharmaceuticals Corporation | 19 | $325 |
| ABBVIE INC. | 12 | $306 |
| AstraZeneca Pharmaceuticals LP | 11 | $272 |
| Merck Sharp & Dohme LLC | 8 | $221 |
| Celgene Corporation | 13 | $219 |
| Genentech USA, Inc. | 10 | $212 |
| Regeneron Healthcare Solutions, Inc. | 7 | $197 |
| PFIZER INC. | 8 | $169 |
| Incyte Corporation | 6 | $162 |
Products named: KEYTRUDA, VENCLEXTA, ERLEADA, Amtagvi, REBLOZYL, OPDIVO, EPKINLY, LYNOZYFIC.
Industry payments across TN — which companies pay providers there.
